MétaCan
Menu
← Back to cohort

Stratification of vulvar squamous cell carcinoma (VSCC) by HPV and P53 status to guide excision: CCTG VU.2 STRIVE study (NCT06358469).

2025· article· en· W4410821065 on OpenAlexafffund
Amy Jamieson, Jessica N. McAlpine, Lien Hoang, Mark Carey, Mary Kinloch, Eric Leung, Vanessa Samouëlian, Stephen Welch, Iwa Kong, Janice S. Kwon, Heather E. Tomalty, Dongsheng Tu, Wendy R. Parulekar

Bibliographic record

VenueJournal of Clinical Oncology · 2025
Typearticle
Languageen
FieldMedicine
TopicCervical Cancer and HPV Research
Canadian institutionsUniversity of British ColumbiaQueen's UniversityLondon Health Sciences CentreSaskatchewan Health AuthorityCentre Hospitalier de l’Université de MontréalSunnybrook Health Science CentreBC Cancer AgencyVancouver Coastal Health
FundersCanadian Institutes of Health Research
KeywordsMedicineDéjà vuVulvar cancerVulvar CarcinomaBasal cellOncologyVulvaInternal medicineDermatologyPsychiatry

Abstract

fetched live from OpenAlex

TPS5637 Background: Early VSCC is treated surgically. The optimal approach to margin re-excision may depend on molecular subtype. HPV associated (HPV-A) VSCC has a good outcome and is radiosensitive; HPV independent (HPV-I) p53 abnormal(p53abn) VSSC has a worse outcome and is less radiosensitive. Methods: Prospective, international, multicentre, phase II platform study enrolling participants with VSCC stratified by HPV status: HPV- Associated (HPV-A) vs HPV-Independent (HPV-I). Criteria: Key eligibility: Primary diagnosis VSCC; surgically staged I-II (FIGO 2021), molecular/ tumour features known: HPV, margin assessment for tumour clearance, dVIN (differentiated-type vulvar intraepithelial neoplasia), p53. Key ineligibility: tumour HPV-I p53 wild-type, recurrent VSCC, stage III-IV, non squamous histotype, planned or previous RT or chemotherapy. Treatment arms: Cohort HPV-A: Margin negative for cancer but < 8mm (regardless of high grade squamous intra epithelial lesion): Active surveillance (AS). Cohort HPV-I p53abn margin: negative for cancer but <8 mm and/or positive for dVIN and/or positive p53abn: 2:1 randomization to re-excision versus AS. Primary objective: To estimate the 3-year local recurrence rate (LRR) for HPV-A and HPV-I VSCC surgically managed based on dVIN/p53 status, tumour margin clearance. Secondary objectives: recurrence free and disease specific survival, OS, economics, patient reported outcomes. Statistical design: Cohort HPV-A: n=120 enrolled over 3 years; the upper limit of a one-sided 95% CI for 3-year LRR would be 26% when the observed 3-year LRR=20%. Interim analyses (IAs) planned at 12, 24, 36 months after 1 st enrollment and final analysis (FA) at 3 years after last enrollment. Cohort HPV-I: n=129, including 10% loss to follow-up, randomized over 3 years to re excision and surveillance arms in 2:1 ratio. 86 on re-excision arm would have at least 85% power with 95% confidence to exclude a 40% 3-year LRR in favour of a lower rate of 25%, while 43 on surveillance arm will enable an estimate of 3-year LRR at an accuracy that the half length of a two-sided 90% CI will be less than 13% when the observed rate is 40%. IA planned at 36 months after 39 th patient enrolled to re-excision arm and FA at 3 years after last enrollment. Conduct to Date : This trial was activated Oct 1, 2024. Two enrollments as of Jan 19 2025. Supported by CCS grant #707213; CIHR #195984. Clinical trial information: NCT06358469 .

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.011
Threshold uncertainty score0.038

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0010.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0110.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.110
GPT teacher head0.517
Teacher spread0.406 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueJournal of Clinical Oncology→Same topicCervical Cancer and HPV Research→French-language works237,207→